We provide you with 20 years of free, institutional-grade data for SAVA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SAVA. Explore the full financial landscape of SAVA stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2025-08-14 | 0001069530 | SAVA | 10-Q | Url |
2025-05-08 | 0001069530 | SAVA | 10-Q | Url |
2025-03-03 | 0001069530 | SAVA | 10-K | Url |
2024-11-07 | 0001069530 | SAVA | 10-Q | Url |
2024-08-08 | 0001069530 | SAVA | 10-Q | Url |
2024-05-10 | 0001069530 | SAVA | 10-Q | Url |
2024-02-28 | 0001069530 | SAVA | 10-K | Url |
2023-11-07 | 0001069530 | SAVA | 10-Q | Url |
2023-08-03 | 0001069530 | SAVA | 10-Q | Url |
2023-05-01 | 0001069530 | SAVA | 10-Q | Url |
2023-02-28 | 0001069530 | SAVA | 10-K | Url |
2022-11-07 | 0001069530 | SAVA | 10-Q | Url |
2022-08-04 | 0001069530 | SAVA | 10-Q | Url |
2022-05-05 | 0001069530 | SAVA | 10-Q | Url |
2022-03-01 | 0001069530 | SAVA | 10-K | Url |
2021-11-15 | 0001069530 | SAVA | 10-Q | Url |
2021-08-04 | 0001069530 | SAVA | 10-Q | Url |
2021-04-29 | 0001069530 | SAVA | 10-Q | Url |
2021-03-23 | 0001069530 | SAVA | 10-K | Url |
2020-11-09 | 0001069530 | SAVA | 10-Q | Url |
2020-08-12 | 0001069530 | SAVA | 10-Q | Url |
2020-05-06 | 0001069530 | SAVA | 10-Q | Url |
2020-03-26 | 0001069530 | SAVA | 10-K | Url |
2019-10-29 | 0001069530 | SAVA | 10-Q | Url |
2019-08-12 | 0001069530 | SAVA | 10-Q | Url |
2019-05-02 | 0001069530 | SAVA | 10-Q | Url |
2019-03-29 | 0001069530 | SAVA | 10-K | Url |
2018-12-18 | 0001069530 | SAVA | S-1 | Url |
2018-10-30 | 0001069530 | SAVA | 10-Q | Url |
2018-07-26 | 0001069530 | SAVA | 10-Q | Url |
2018-05-09 | 0001069530 | SAVA | 10-Q | Url |
2018-02-06 | 0001069530 | SAVA | 10-K | Url |
2017-11-01 | 0001069530 | SAVA | 10-Q | Url |
2017-08-09 | 0001069530 | SAVA | 10-Q | Url |
2017-04-26 | 0001069530 | SAVA | 10-Q | Url |
2017-03-07 | 0001069530 | SAVA | 10-K | Url |
2016-10-26 | 0001069530 | SAVA | 10-Q | Url |
2016-07-19 | 0001069530 | SAVA | 10-Q | Url |
2016-05-05 | 0001069530 | SAVA | 10-Q | Url |
2016-03-03 | 0001069530 | SAVA | 10-K | Url |
2015-11-09 | 0001069530 | SAVA | 10-Q | Url |
2015-07-23 | 0001069530 | SAVA | 10-Q | Url |
2015-05-08 | 0001069530 | SAVA | 10-Q | Url |
2015-02-18 | 0001069530 | SAVA | 10-K | Url |
2014-11-05 | 0001069530 | SAVA | 10-Q | Url |
2014-08-06 | 0001069530 | SAVA | 10-Q | Url |
2014-05-07 | 0001069530 | SAVA | 10-Q | Url |
2014-02-05 | 0001069530 | SAVA | 10-K | Url |
2013-11-01 | 0001069530 | SAVA | 10-Q | Url |
2013-08-01 | 0001069530 | SAVA | 10-Q | Url |
2013-04-24 | 0001069530 | SAVA | 10-Q | Url |
2013-02-08 | 0001069530 | SAVA | 10-K | Url |
2012-11-09 | 0001069530 | SAVA | 10-Q | Url |
2012-08-02 | 0001069530 | SAVA | 10-Q | Url |
2012-05-08 | 0001069530 | SAVA | 10-Q | Url |
2012-02-09 | 0001069530 | SAVA | 10-K | Url |
2011-11-03 | 0001069530 | SAVA | 10-Q | Url |
2011-08-04 | 0001069530 | SAVA | 10-Q | Url |
2011-04-27 | 0001069530 | SAVA | 10-Q | Url |
2011-02-03 | 0001069530 | SAVA | 10-K | Url |
2010-10-29 | 0001069530 | SAVA | 10-Q | Url |
2010-07-29 | 0001069530 | SAVA | 10-Q | Url |
2010-04-30 | 0001069530 | SAVA | 10-Q | Url |
2010-02-01 | 0001069530 | SAVA | 10-K | Url |
2009-10-30 | 0001069530 | SAVA | 10-Q | Url |
2009-08-05 | 0001069530 | SAVA | 10-Q | Url |
2009-05-06 | 0001069530 | SAVA | 10-Q | Url |
2009-02-13 | 0001069530 | SAVA | 10-K | Url |
2008-10-29 | 0001069530 | SAVA | 10-Q | Url |
2008-07-30 | 0001069530 | SAVA | 10-Q | Url |
2008-05-07 | 0001069530 | SAVA | 10-Q | Url |
2008-02-13 | 0001069530 | SAVA | 10-K | Url |
2007-11-02 | 0001069530 | SAVA | 10-Q | Url |
2007-08-09 | 0001069530 | SAVA | 10-Q | Url |
2007-05-04 | 0001069530 | SAVA | 10-Q | Url |
2007-02-26 | 0001069530 | SAVA | 10-K | Url |
2006-11-03 | 0001069530 | SAVA | 10-Q | Url |
2006-08-09 | 0001069530 | SAVA | 10-Q | Url |
2006-05-10 | 0001069530 | SAVA | 10-Q | Url |
2006-02-24 | 0001069530 | SAVA | 10-K | Url |
2005-11-07 | 0001069530 | SAVA | 10-Q | Url |
2005-07-29 | 0001069530 | SAVA | 10-Q | Url |
2005-05-02 | 0001069530 | SAVA | 10-Q | Url |
2005-02-16 | 0001069530 | SAVA | 10-K | Url |
2004-11-05 | 0001069530 | SAVA | 10-Q | Url |
2004-07-26 | 0001069530 | SAVA | 10-Q | Url |
2004-04-29 | 0001069530 | SAVA | 10-Q | Url |
2004-03-12 | 0001069530 | SAVA | 10-K | Url |
2003-10-31 | 0001069530 | SAVA | 10-Q | Url |
2003-07-31 | 0001069530 | SAVA | 10-Q | Url |
2003-05-05 | 0001069530 | SAVA | 10-Q | Url |
2003-03-17 | 0001069530 | SAVA | 10-K | Url |
2002-11-12 | 0001069530 | SAVA | 10-Q | Url |
2002-08-13 | 0001069530 | SAVA | 10-Q | Url |
2002-05-14 | 0001069530 | SAVA | 10-Q | Url |
2002-03-22 | 0001069530 | SAVA | 10-K | Url |
2001-11-13 | 0001069530 | SAVA | 10-Q | Url |
2001-08-10 | 0001069530 | SAVA | 10-Q | Url |
2001-05-11 | 0001069530 | SAVA | 10-Q | Url |
2000-11-13 | 0001069530 | SAVA | 10-Q | Url |
2000-08-11 | 0001069530 | SAVA | 10-Q | Url |
2000-03-14 | 0001069530 | SAVA | S-1 | Url |
Cassava Sciences, Inc(NASDAQ:SAVA)


Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-b...
Website: https://www.cassavasciences.com/
Founded: 1998
Full Time Employees: 9
CEO: Remi Barbier
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about SAVA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.